ARROWHEAD PHARMACEUTICALS, INC. — Investor Relations & Filings
Filings indexed
1,039
across all filing types
Latest filing
2026-05-07
Regulatory Filings
Country
US
United States of America
Listing
US
ARWR
Arrowhead Pharmaceuticals, Inc. is a biotechnology company that develops medicines to treat intractable diseases by silencing the genes that cause them. The company utilizes its proprietary RNA interference (RNAi) platform to create therapies that target disease pathways previously considered 'undruggable.' Arrowhead's development pipeline is focused on a broad range of therapeutic areas, including cardiometabolic, pulmonary, neuromuscular, and liver diseases. The company advances a portfolio of clinical-stage candidates designed to address significant unmet medical needs.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| S-8 - ARROWHEAD PHARMACEUTICALS, INC. (0000879407) (Filer) | 2026-05-07 | English | |
| 10-Q | 2026-05-07 | English | |
| 8-K - ARROWHEAD PHARMACEUTICALS, INC. (0000879407) (Filer) | 2026-05-07 | English | |
| Major Shareholding Notification 2026 | 2026-05-06 | English | |
| Major Shareholding Notification 2026 | 2026-04-29 | English | |
| Major Shareholding Notification 2026 | 2026-04-28 | English |
Browse filings by year
18 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 43600570 | S-8 - ARROWHEAD PHARMACEUTICALS, INC. (0000879407) (Filer) | 2026-05-07 | English | ||
| 46149826 | 10-Q | 2026-05-07 | English | ||
| 43480488 | 8-K - ARROWHEAD PHARMACEUTICALS, INC. (0000879407) (Filer) | 2026-05-07 | English | ||
| 46149831 | Major Shareholding Notification 2026 | 2026-05-06 | English | ||
| 46149840 | Major Shareholding Notification 2026 | 2026-04-29 | English | ||
| 46149844 | Major Shareholding Notification 2026 | 2026-04-28 | English | ||
| 46149849 | Major Shareholding Notification 2026 | 2026-04-24 | English | ||
| 33051854 | SCHEDULE 13G/A - ARROWHEAD PHARMACEUTICALS, INC. (0000879407) (Subject) | 2026-03-26 | English | ||
| 46149856 | 8-K | 2026-03-20 | English | ||
| 32882864 | 10-Q - ARROWHEAD PHARMACEUTICALS, INC. (0000879407) (Filer) | 2026-02-05 | English | ||
| 24687705 | 8-K Filing | 2026-02-05 | English | ||
| 24687727 | DEF 14A Filing | 2026-01-27 | English | ||
| 32882862 | ARS - ARROWHEAD PHARMACEUTICALS, INC. (0000879407) (Filer) | 2026-01-27 | English | ||
| 46149866 | DEFA14A | 2026-01-26 | English | ||
| 24687718 | 8-K Filing | 2026-01-12 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Alembic Ltd
Vertically integrated producer of generic pharmaceuticals a…
|
ALEMBICLTD | IN | Manufacturing |
|
ALEMBIC PHARMACEUTICALS LIMITED
Vertically integrated developer of generic drugs, APIs, and…
|
APLLTD | IN | Manufacturing |
|
ALIVUS LIFE SCIENCES LIMITED
Produces and distributes diverse pharmaceuticals across mul…
|
ALIVUS | IN | Manufacturing |
|
ALK-Abelló
A pharmaceutical company specializing in allergy prevention…
|
ALK | DK | Manufacturing |
|
Alkaloid AD
Manufactures generic pharmaceuticals, cosmetics, and chemic…
|
ALK | MK | Manufacturing |
|
Alkem Laboratories Limited
Develops, manufactures, and markets pharmaceutical and nutr…
|
ALKEM | IN | Manufacturing |
|
Alkermes plc.
Develops and commercializes medicines for central nervous s…
|
ALKS | US | Manufacturing |
|
Allarity Therapeutics, Inc.
A clinical-stage biopharma using diagnostics to develop tar…
|
ALLR | US | Manufacturing |
|
ALLERGY THERAPEUTICS PLC
Immunology company developing aluminum-free vaccines and th…
|
AGY | GB | Manufacturing |
|
Alliance Growers Corp.
Diversified global medical cannabis company focused on CBD …
|
ALGWF | CA | Manufacturing |
ARROWHEAD PHARMACEUTICALS, INC. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/31071/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=31071 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=31071 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=31071 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 31071}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for ARROWHEAD PHARMACEUTICALS, INC. (id: 31071)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.